Business UpdateMay 20, 2026, 04:07 PM
Equillium to Host Investor Event on AhR/miR-124 Preclinical Data
AI Summary
Equillium, Inc. announced it will host a virtual investor event on May 27, 2026, at 11:00 AM ET. The event will feature new preclinical data presented by Chief Scientific Officer Stephen Connelly, Ph.D., focusing on AhR modulators and the relationship between AhR activation and miR-124 induction. These findings aim to provide a unifying mechanistic framework for the paradoxical relationship between AhR and miR-124, which has implications for developing therapies targeting this axis in inflammatory diseases. The webinar will also include a live question-and-answer session with management.
Key Highlights
- Equillium to host a virtual investor event on Wednesday, May 27, 2026, at 11:00 AM ET.
- Chief Scientific Officer Stephen Connelly, Ph.D., will present new preclinical data.
- Data will evaluate AhR modulators and the relationship between AhR activation and miR-124 induction.
- New insights support a unifying mechanistic framework linking AhR signaling to miR-124.
- Findings have implications for developing therapies targeting the AhR/miR-124 axis in inflammatory disease.
- A live question-and-answer session with management will follow the presentations.
Price Impact
More from EQ